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Abstract
The exploitation of 2-bromo-1,4-naphthoquinone (NQBr) as a selective redox label for the determination of reduced
thiol functionalities (RSH) has been investigated. The system is selective for RSH functionality, giving distinct
voltammetric signals for glutathione and cysteine but can also be adapted for broad spectrum thiol detection. Ion
chromatographic protocols based on conductimetric detection enable total RSH analysis (protein and monomolecular
moieties) within human plasma. Bromide released through the reaction can be easily quantified and integrated within
normal IC measurements. The efficacy of the approach has been assessed and the response validated through
comparison with the standard colorimetric technique.
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1. Introduction
The clinical value of measuring reduced thiol concentration
has long been recognized and it has been suggested as a
semiquantitative handle that, in the appropriate context,
could be used to monitor the progress of illnesses exacer-
bated by oxidative stress processes [1, 2]. The depletion in
concentration of the various sulfur moieties has also been
proffered as a possible early warning indicator for the onset
of various clinical complications that include: diabetes [3 –
5]; various forms of cancer [6, 7]; kidney function [8, 9]
and preeclampsia [10, 11].Utilization of suchmeasurements
within routine clinical settings, however, has largely been
restricted as a consequence of the expense and difficulties
associated with the analysis. While more commonly asso-
ciated with research studies, there is considerable merit in
making such measurements available within mainstream
health care provision. The aim of the present communica-
tion has been to assess the electroanalytical options that a
naphthoquinone-bromide detection system can provide for
the analysis of thiols within conventional biofluids such as
plasma.
Several quinone systems have been investigated as
potential indicators for reduced thiol species [12 – 14]. The
advantage of the system proposed herein relies on the
versatility of the fact that there are a number of detection
routes through which the analytical signal can be extracted.
The core detection pathway is detailed in Scheme 1 and
involves the nucleophilic substitution of a bromide derivat-
ized quinone indicator (I). In the presence of reduced thiols Scheme 1. Naphthoquinone bromide (NQBr) reaction pathway.
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such as glutathione (III), it could be anticipated that a
relatively rapid reaction would occur leading to the for-
mation of the corresponding quinone-thiol conjugate (IV)
and release of bromide ion. The analytical options stem
from examining either the consumption of the naphthoqui-
none-bromide indicator, the production of the conjugate or
the release of bromide ion. The last two are arguably better
solutions as, in either case, a positive increment to the
analytical signals should be obtained.
The investigation has sought to assess the electrochemical
properties possessed by the quinone system in relation to its
use as a label for reduced thiol species. Selectivity, sensi-
tivity, the extraction of an unambiguous signal and the
development of a system that can be readily transferred to
the analysis of real samples (human plasma) are the core
issues that need to be addressed.
2. Experimental
2.1. Methods and Materials
All reagents were of the highest grade available and used
without further purification. All standards were prepared
using UHQ deionized water (Elga,UK) with a resistivity of
not less than 18 MWÿ1cm. Electrochemical measurements
were conducted using a mAutolab type III computer
controlled potentiostat (Eco-Chemie, Utrecht, The Nether-
lands) using a three electrode configuration consisting of a
glassy carbon working electrode (3 mm diameter, BAS
Technicol, UK), a platinum wire counter electrode and a
3 M NaCl Ag j AgCl half cell reference electrode (BAS
Technicol, UK). All measurements were done under nitro-
gen. Chromatographic analysis was carried out in isocratic
mode with a Dionex 120 DX series ion chromatography
system with a 25 mL sample loop. The mobile phase
consisted of nitrogen purged sodium carbonate/bicarbonate
(3.5 mM/1 mM) at a flow rate of 1.5 mL/min. Detection was
achieved through the use of an integrated conductivity cell
thermostatted at 35 8C. Absorbance spectra were obtained
using a Perkin Elmer Lambda 25 spectrometer. NMR
spectra were measured on a JEOL ECX 400 MHz spec-
trometer. Chemical shifts are reported in parts per million
(ppm) downfield from tetramethylsilane (TMS). Mass
spectra were recorded on a Micromass Platform LC-ESI-
MS. Flash chromatography was performed on 40 – 63 silica
gel (Merck). IR data was recorded on a Perkin Elmer
Spectrum 100 Series with a Universal ATR Sampling
Accessory.
2.2. Preparation of 2-Bromo-1,4-Naphthoquinone
(NQBr)
The preparation route followed was adapted from a
previous method [15] with the reagents obtained as the
highest grade available from Sigma-Aldrich. These were
used as received without further purification. A solution of
1-naphthol (0.72 g, 0.50 mmol) in glacial acetic acid (50 mL)
was added to a stirring solution of N-bromosuccinimide
(3.56 g, 20 mmol) in 2 :1 water/glacial acetic acid (150 mL)
at room temperature over a period of 60 minutes. The
mixturewas stirred at room temperature for 12h followedby
heating to 50 – 60 8Cwith stirring for 1h. Subsequently,water
(100 mL) was added to the reaction mixture followed by
extraction into ethyl acetate (3 100 mL).Theorganic layer
was combined and washed with 5 M NaHCO3 solution,
dried over Na2SO4, filtered and concentrated under vacuum
to yield the crude product. Purification using column
chromatography on silica gel with ethyl acetate and hexane
(7 :3) as eluent yielded the 2-bromo-1,4-naphthoquinone
(0.65 g, 54.4%) as a yellow powder.
1HNMR(CDCl3): d 8.19 – 8.17 (m, 1H,ArÿH), 8.10 – 8.08
(m, 1H, ArÿH), 7.80 – 7.77 (m, 2H, ArÿH), 7.52 (s, 1H,
ArÿH); 13C NMR (CDCl3): d 126.9, 127.9, 131.7, 134.2,
134.5, 134.6, 140.2, 140.4, 177.9, 182.5; IR (ATR): 3055
(ArÿH), 1676 (C¼O), 1656 (C¼O), 1588 (C¼O), 1292
(C¼O), 1244 (C¼O), 1058 (Ar-Br); ESI-MS (m/z) 236
[MþH]ÿ.
2.3. Clinical Samples
Aclinical trial involving five volunteers was conducted. The
participants were aged between 24 and 37. Blood was
collected in heparinized gel permeation vaccutainers and
then centrifuged at 3000 rpm for 5 minutes. The plasma was
withdrawn and stored atÿ18 8C. The concentration of total
reduced thiol was assessed prior to storage and after
defrosting using an established Ellmans Assay protocol.
This consisted of adding 0.1 mL of either standard solution
or plasma sample to 1.9 mL of Ellmans Reagent (pH 8)
with the calibration and analysis data taken at 412 nm[3, 5, 6,
14, 16].
2.4. Ion Chromatographic Assay Procedures
A standard solution (5 mM) of 2-bromo-1,4-naphthoqui-
none (NQBr) was prepared in HPLC grade acetonitrile.
Calibration solutionswere preparedbydilution froma stock
solution of glutathione (10 mM dissolved in electrolyte
containing chloride, nitrate and phosphate, each at 100 mg/
L). The analysis samples were prepared by adding 325 mL of
the NQBr solution to 175 mL of the appropriate standard
(0.025 – 1.0 mM). The solution was gently mixed and then
injected into the IC through a 0.45 micron filter (Millipore).
An analogous procedure was used for the plasma samples.
Upon the introduction of the acetonitrile indicator solution,
rapid precipitation of protein was observed. The resulting
slurry was then centrifuged at 10000 rpm for 5 minutes and
the supernatant injected as before.
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3. Results and Discussion
Cyclic voltammograms detailing the response of NQBr
(0.5 mM, pH 7) towards increasing additions of glutathione
at a glassy carbon electrode are detailed in Figure 1A. In the
absence of the thiol, the quinone exhibits the characteristic
2e, 2Hþ reduction (ÿ0.18 V) and corresponding oxidation
(ÿ0.11 V). Upon introducing glutathione (55 mM incre-
ments), the reduction process diminishes inmagnitude and a
second reduction process begins to emerge at ÿ0.26 V. The
latter corresponds to the production of the quinone-thiol
conjugate (NQ-SG) as indicated in Scheme 1 (IV). The
conjugate process can be seenmore clearly when examining
the square-wave voltammograms (Fig. 1B).
Similar responses were observed from pH 3 to pH 9,
sufficient to cover most biofluid environments, with the
response to glutathione (55 mM) found to be consistent as
shown in Figure 2. Degradation of the NQBr indicator at
pH 9 can be seen with the appearance of a number of
secondary peaks observable on the voltammogram in the
absence of any thiol. These increase with time and highlight
the reactivity of the bromide derivative but also its
instability at the higher pH. An important point to note
however is the continued reactivity toward the thiol at low
pH. This is in marked contrast to conventional quinone
systems. The chief advantage, beyond simply increasing the
range of applicability, is that it should enhance selectivity
towards thiol functionality as it could be expected thatmost,
if not all amine functionality will be protonated at such low
pH and hence possess negligible nucleophilic character.
The response of the NQBr indicator to cysteine (CSH) is
highlighted in Figures 3Aand 3B.The voltammetric profiles
are, on initial inspection, similar to that observed with
glutathione in that the reduction peak for the NQBr
indicator decreases with increasing additions of cysteine
(55 mM). Closer examination of the cyclic voltammograms,
detailed in Figure 3A, reveals the appearance of a new
species with the reduction/oxidation peaks observed at
ÿ0.46 Vandÿ0.37 V respectively. Inspection of the square-
wave response under the same conditions (Fig. 3B) however
highlights the existence of two reaction products. This is in
contrast to the responsewith glutathionewhere only a single
reaction productwas observed. The former is ascribed to the
formation of the simple conjugate, as per glutathione [17],
however, the second, more cathodic process is attributed to
the subsequent cyclization of the initial conjugate. The
proposed reaction pathway is outlined in Scheme 2. The
absence of the second reaction product in Figure 1 is most
likely due to the inability of the glutathione to form the six
member ring possessed by the quinone-cysteine product.
Support for the cyclization process has been found in studies
Fig. 2. Cyclic voltammograms highlighting the influence of pH
on the response of a glassy carbon electrode towards 0.5 mM
NQBr in the presence of increasing cysteine (55 mM). Scan Rate:
0.1 V/s.
Fig. 1. Cyclic (A) and square-wave (B) voltammograms detailing
the response of a glassy carbon electrode towards 0.5 mM NQBr
(pH 7) in the presence of increasing glutathione, GSH, (55 mM).
Scan Rate: 0.1 V/s.
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of thiol interactions with hypocrellin derivatives and con-
firmed by both NMR and mass spectroscopic analysis [18].
In the latter, cysteine has been found to react with quinone
moieties of the macromolecular species in much the same
way as the NQBr with the consequent cyclic imine
(Scheme 2, VII –VIII).
The electroanalytical exploitation would, at first sight,
appear to be quite promising and is strengthened by the fact
that the quinone indicator is insensitive to most other
functionalities under the short timescale of the voltammet-
ric investigation (5 min).Therewereno responses to alkyl or
aryl amines nor imidazole derivatives, such as histidine, even
when present at a 100 fold excess [13]. The main problem
however relates to the fact that the analytical signal is
derived from the decrease in the quinone reduction peak.
While the indicator is selective for RSH functionalities, the
concentration of the thiol derived from using the inverse of
the peak height would make such a strategy highly
susceptible to errors resulting from simple changes in
electrode area. This would be particularly true where
biological fluids are being analyzed as surface fouling,
inevitable in such environments, would lead to an over-
estimate of the thiol concentration.
The emergence of the conjugate peaks in the square-wave
voltammograms (Figure 1B and 3B), in contrast to the
previous approach, provide positive signals. Unfortunately,
they are not sufficiently resolved to allow unambiguous
quantification. The secondary product observed with cys-
teine (Fig. 3B), however, does provide an option for the
selective quantification of this component. The response
was found to be non linear but rapidly plateaus. There is an
adsorptive component to signal as expected given the
tricyclic nature of the product (Scheme 2,VII –VIII).While
it could be adapted to the measurement of low levels of
cysteine, the irreproducible nature of the system would
impede widespread adoption of such an approach.
Themain value of the NQBr indicator is more likely to lie
in its integration within hybrid liquid chromatography (LC)
systems in which column resolution of the various compo-
nents will allow unambiguous quantification of the thiol
content. It could be anticipated that the quinone redox
centre would provide a versatile handle for electrochemical
detectionwithin conventional LC systems. There is however
an alternative strategy, ion chromatography of the resulting
Scheme 2. Cyclization of the cysteine-quinone conjugate.
Fig. 3. Cyclic (A) and square-wave (B) voltammograms detailing
the response of a glassy carbon electrode towards 0.5 mM NQBr
(pH 7) in the presence of increasing cysteine, CSH, (55 mM,
dashed line). Scan Rate: 0.1 V/s.
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bromide ion. As the NQBr is selective for reduced thiol
functionality, then the release of bromide would represent
the stoichiometric equivalent of the available SH function-
alities. This should provide a simple means of acquiring the
total RSH content.
The ion chromatographic response of theNQBr indicator
towards increasing glutathione (0.06 mM–1.5 mM) is
shown in Figure 4A. Four peaks are observed throughout
and correspond to chloride, nitrite, nitrate and phosphate,
all of which are liable to be found within most typical
biofluids. The release of bromide as a consequence of the
NQBr-glutathione reaction is observed as a distinct peak
between the nitrite and nitrate signals. Near identical
responses are observed for cysteine and albumin, as
expected given that bromide is the principal agent in all
cases, and allows the measurement of both low molecular
weight and macromolecular species. The main requirement
is the presence of the free SH group. There is, however, no
opportunity for speciation, in contrast toLCmethodologies,
but the aim here has been focused on obtaining the total
reduced thiol measurement. The response was linear over
the range 15 mM–3.5 mM RSH. The calibration data
relating to the bromide peak was found to be: Response
(mS)¼ 3.80 104 [mol/L RSH]ÿ 0.014, N¼ 8, R2¼ 0.9997).
The recoveries for 80 and 500 mMglutathionewere 92%and
96% respectively. The limit of detection was found to be
9 mM (based on 3sb) and is more than adequate to cover the
broad range (300 – 600 mM) typical for total reduced thiol
measurements within plasma [3 – 8].
3.1. Clinical Study
The ion chromatographic response to plasma before (dotted
line) and after (solid line) treatmentwith theNQBr solution
is shown in Figure 4B. The response towards the simple
electrolyte solution is also included (inverted – dotted line)
to enable the clear identification of the peaks. The central
peak, while predominantly chloride, is liable to contain a
host of components and it was not possible to isolate these in
the present study. Clear resolution between the composite
chloride peak, bromide and the other anionic electrolytes is
possible and contrast the direct electrochemical measure-
ments highlighted in Figures 1 – 3. Bromide is observable in
the untreated plasma with the endogenous concentration
between different plasma samples found to range from 49 –
72 mM and is consistent with the values found in previous
investigations [19 – 21]. The presence of bromide in the
untreated plasma does not unduly compromise the mea-
surement as the appropriate correction can be made using a
before and after subtraction. The results from the five
plasma samples (after subtraction of endogenous bromide)
are detailed in Table 1 along with the results obtained using
the standard Ellmans reagent system [3, 5, 6, 16]. In each
case, the analysis was done in triplicate with the intra assay
variation being less than 5%. It can be argued that where
gross changes in thiol concentration are to be used as a
screening system for identifying underlying illness, then the
Fig. 4. Ion chromatograms detailing A) the release of bromide as
a consequence of the reaction of NQBr with increasing concen-
trations of glutathione (250 mM increments) and B) the response
obtained to plasma before (dashed line) and after (solid line)
reaction with NQBr.
Table 1. Table 1. Plasma thiol concentrations. Each measurement
based on three replicates.
Plasma thiol NQBr IC Ellmans reagent
Gender Age mM (%RSD) (%RSD) mM
M 37 0.362 (3.8) 0.373 (3.5)
F 24 0.365 (2.6) 0.361 (1.2)
M 30 0.334 (3.2) 0.374 (2.5)
F 27 0.406 (3.2) 0.401 (2.9)
F 37 0.384 (2.1) 0.391 (2.6)
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relatively constant nature of the endogenous bromide will
have little influence and hence only a single measurement
would be necessary. This is corroborated by recent studies
where the RSH levels measured in diabetics suffering from
vascular complications were 25 – 33% lower than that of the
corresponding control group [3, 4]. While similar variations
have been observed with preeclamptic pregnancies [10, 11],
the difference can be substantially greater in cancer patients
where, in the case of oral squamous cell carcinoma, the
levels were decreased by more than 50% when compared
with healthy controls [6]. This can represent a depletion of
more than 0.25 mM from the respective control group.
4. Conclusions
Thebromo-quinone derivative provides a versatile platform
from which to explore quinone-thiol interactions but the
analytical exploitation is limited by poor resolution between
the indicator and reaction product. Using the bromide ion
released in the course of the reaction, however, provides a
more valuable diagnostic handle. The potential of the latter
is twofold, an early warning indicator for the onset of
underlying oxidative injury and a marker that could allow
the progress of the illness and the subsequent treatment to
be assessed. Routine screening of RSH concentration could
be easily achieved by minor modification to existing IC
protocols. It overcomes the problems of dealing with highly
colored matrices that afflict spectroscopic protocols such as
Ellmans and, as demonstrated in Figure 2, can be used
withinmatrices covering awider pHrange than that dictated
by the spectroscopic system.More importantly, obviates the
need for requesting a separate test set as it can be
accomplished in the normal course of electrolyte measure-
ments without compromising the integrity of the latter.
Given that the system proposed here offers a relevant
detection range, simplicity of operation and utilises estab-
lished technology it should therefore be capable of wide-
spread application.
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